Go on a journey with 2 men, 2 prostate cancer diagnoses, 2 distinct plans for treatment chosen in partnership with their physicians. Witness patients at the forefront of healthcare. Watch Choices, Hop ...

Dr. Clark Wilson, a board-certified urologist at UT Health East Texas, stopped by East Texas Live on Monday to discuss the ...

The FDA expanded the approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and are considered appropriate to ...

A Wigan Athletic fan is cycling to all 92 clubs in the Premier League and English Football League (EFL) within 50 days in ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor pathway inhibitor.

While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...

Assessment of PSA level for three months after radical prostatectomy for prostate cancer may minimize overtreatment.

British royal family news reveals that King Charles has returned to Clarence House after a brief visit to the hospital on ...

Jyong Biotech Ltd. (Revived IPO) (MENS) is planning to raise $22 million in an initial public offering (IPO) on Thursday, April 3rd, IPO Scoop reports. The company plans to issue 2,700,000 shares at ...